
Danish Lundbeck's medications target diseases such as epilepsy, depression, anxiety, Huntington's disease, and Alzheimer's disease. (Archive photo). Photo: Ida Guldbæk Arentsen/Ritzau Scanpix
“Lundbeck outbid in war for Irish company”
Danish pharmaceutical company Lundbeck was outbid in the acquisition battle for Irish company Avadel, known for producing a narcolepsy treatment. Initially, Avadel considered Lundbeck’s offer superior to Alkermes’. However, Alkermes increased its bid, and Lundbeck’s offer is no longer deemed...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.